Envestnet Asset Management’s Catalyst Pharmaceutical CPRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.2M | Buy |
101,607
+23,412
| +30% | +$508K | ﹤0.01% | 2759 |
|
|
2025
Q1 | $1.9M | Buy |
78,195
+13,800
| +21% | +$335K | ﹤0.01% | 2772 |
|
|
2024
Q4 | $1.34M | Buy |
64,395
+39,836
| +162% | +$831K | ﹤0.01% | 2958 |
|
|
2024
Q3 | $488K | Sell |
24,559
-6,919
| -22% | -$138K | ﹤0.01% | 3548 |
|
|
2024
Q2 | $488K | Buy |
31,478
+1,366
| +5% | +$21.2K | ﹤0.01% | 3472 |
|
|
2024
Q1 | $480K | Sell |
30,112
-6,603
| -18% | -$105K | ﹤0.01% | 3456 |
|
|
2023
Q4 | $617K | Buy |
36,715
+13,706
| +60% | +$230K | ﹤0.01% | 3210 |
|
|
2023
Q3 | $269K | Buy |
23,009
+1,120
| +5% | +$13.1K | ﹤0.01% | 3583 |
|
|
2023
Q2 | $294K | Buy |
21,889
+3,153
| +17% | +$42.4K | ﹤0.01% | 3499 |
|
|
2023
Q1 | $311K | Buy |
+18,736
| New | +$311K | ﹤0.01% | 3425 |
|